Biocardia, Inc.
Clinical trials sponsored by Biocardia, Inc., explained in plain language.
-
Stem cell trial for COVID lung damage halted before start
Disease control TerminatedThis study aimed to test a stem cell treatment for people recovering from severe COVID-19 lung problems. The treatment used donor stem cells to help repair lung damage. However, the study was withdrawn before any participants were enrolled.
Phase: PHASE1 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
Heart patients' own cells may ease crippling chest pain
Disease control OngoingThis study tests whether a patient's own bone marrow cells can help people with severe chest pain that doesn't improve with standard treatments. About 343 adults with chronic heart pain will either receive the cell therapy or a sham procedure. The main goal is to see if the treat…
Phase: NA • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
Could stem cells repair damaged hearts? new trial underway
Disease control OngoingThis study tests if stem cells from donors can help people with heart failure caused by a past heart attack. The cells are delivered directly to the heart using a special catheter. The goal is to see if this treatment is safe and can improve heart function, reduce hospital stays,…
Phase: PHASE1, PHASE2 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated May 26, 2026 12:01 UTC